Form 8-K - Current report:
SEC Accession No. 0001558370-25-000603
Filing Date
2025-02-03
Accepted
2025-02-03 16:10:23
Documents
14
Period of Report
2025-01-31
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K nxtc-20250131x8k.htm   iXBRL 8-K 44830
  Complete submission text file 0001558370-25-000603.txt   173812

Data Files

Seq Description Document Type Size
2 EX-101.SCH nxtc-20250131.xsd EX-101.SCH 4101
3 EX-101.DEF nxtc-20250131_def.xml EX-101.DEF 2850
4 EX-101.LAB nxtc-20250131_lab.xml EX-101.LAB 17254
5 EX-101.PRE nxtc-20250131_pre.xml EX-101.PRE 11364
16 EXTRACTED XBRL INSTANCE DOCUMENT nxtc-20250131x8k_htm.xml XML 4849
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

EIN.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38905 | Film No.: 25582606
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)